Eleven Years of Menicon Z Night Contact Lens Wear in Reducing Myopia Progression in Children (MCOS11)
Primary Purpose
Myopia, Progressive, Children, Only
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Menicon Z Night
Control
Sponsored by
About this trial
This is an interventional treatment trial for Myopia, Progressive
Eligibility Criteria
Inclusion Criteria:
- Be 6 to 12 years of age, both ages inclusive
- A low-to-moderate level of myopia (between 0.75 and 4.00 D) and of astigmatism (≤ 1.00 D)
- Neophyte contact lens wearer
- Be successfully fitted with spectacles or orthokeratology contact lenses
- Be able to achieve, through spherical refraction correction, a logMAR visual acuity of 0.8 or better in each eye
- Be willing and able to follow the subject instructions and to meet the protocol-specified schedule of follow-up visits
- White European ethnicity
Exclusion Criteria:
- Systemic or ocular disease affecting ocular health
- Use of any systemic or topical medications that could affect ocular physiology or contact lens performance
- Any lid or anterior segment abnormalities for which contact lens wear could be contraindicated
- CCLRU grade ≥ 2 for any given anterior segment ocular clinical signs
- Aphakic, amblyopic, and atopic individuals
- Refractive astigmatism ≥ ½ spherical refraction
- Previous contact lens wear
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Menicon Z Night
Control
Arm Description
The experimental arm consist of a group of Menicon Z Night orthokeratology contact lens wearers
The active comparator arm consist of a control group of distance, single-vision glasses and contact lens wearers
Outcomes
Primary Outcome Measures
Axial length
To compare axial length growth of white European myopic children wearing Menicon Z Night orthokeratology contact lenses to a control group of distance, single-vision glasses and soft contact lens wearers. Measurements of axial length were taken with the Zeiss IOLMaster (Carl Zeiss Jena GmbH, Jena, Germany). Three separate measurements of axial length were recorded per subject and per visit, and a mean obtained.
Secondary Outcome Measures
Full Information
NCT ID
NCT04806711
First Posted
March 10, 2021
Last Updated
March 17, 2021
Sponsor
Menicon Co., Ltd.
Collaborators
Universidad Europea de Madrid, Clinica novovision
1. Study Identification
Unique Protocol Identification Number
NCT04806711
Brief Title
Eleven Years of Menicon Z Night Contact Lens Wear in Reducing Myopia Progression in Children
Acronym
MCOS11
Official Title
Eleven Years of Menicon Z Night Contact Lens Wear in Reducing Myopia Progression in Children
Study Type
Interventional
2. Study Status
Record Verification Date
March 2021
Overall Recruitment Status
Completed
Study Start Date
March 1, 2007 (Actual)
Primary Completion Date
March 1, 2018 (Actual)
Study Completion Date
March 1, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Menicon Co., Ltd.
Collaborators
Universidad Europea de Madrid, Clinica novovision
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
To compare axial length growth of white European myopic children wearing Menicon Z Night orthokeratology contact lenses to a control group of distance, single-vision glasses and contact lenses over an 11-year period.
Detailed Description
This prospective, controlled, parallel, longitudinal study compared the axial length growth of white European myopic children wearing Menicon Z Night orthokeratology contact lenses to a control group of distance, single-vision glasses and or distance, single-vision soft contact lenses over an 11-year period.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myopia, Progressive, Children, Only
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Prospective, controlled, parallel, longitudinal
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
20 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Menicon Z Night
Arm Type
Experimental
Arm Description
The experimental arm consist of a group of Menicon Z Night orthokeratology contact lens wearers
Arm Title
Control
Arm Type
Active Comparator
Arm Description
The active comparator arm consist of a control group of distance, single-vision glasses and contact lens wearers
Intervention Type
Device
Intervention Name(s)
Menicon Z Night
Intervention Description
Menicon Z Night orthokeratology contact lenses were used to assess their efficacy in reducing myopia progression in children
Intervention Type
Device
Intervention Name(s)
Control
Intervention Description
Distance, single-vision glasses were used as a control
Primary Outcome Measure Information:
Title
Axial length
Description
To compare axial length growth of white European myopic children wearing Menicon Z Night orthokeratology contact lenses to a control group of distance, single-vision glasses and soft contact lens wearers. Measurements of axial length were taken with the Zeiss IOLMaster (Carl Zeiss Jena GmbH, Jena, Germany). Three separate measurements of axial length were recorded per subject and per visit, and a mean obtained.
Time Frame
11 years
10. Eligibility
Sex
All
Gender Based
Yes
Gender Eligibility Description
White European
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Be 6 to 12 years of age, both ages inclusive
A low-to-moderate level of myopia (between 0.75 and 4.00 D) and of astigmatism (≤ 1.00 D)
Neophyte contact lens wearer
Be successfully fitted with spectacles or orthokeratology contact lenses
Be able to achieve, through spherical refraction correction, a logMAR visual acuity of 0.8 or better in each eye
Be willing and able to follow the subject instructions and to meet the protocol-specified schedule of follow-up visits
White European ethnicity
Exclusion Criteria:
Systemic or ocular disease affecting ocular health
Use of any systemic or topical medications that could affect ocular physiology or contact lens performance
Any lid or anterior segment abnormalities for which contact lens wear could be contraindicated
CCLRU grade ≥ 2 for any given anterior segment ocular clinical signs
Aphakic, amblyopic, and atopic individuals
Refractive astigmatism ≥ ½ spherical refraction
Previous contact lens wear
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
22729437
Citation
Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutierrez-Ortega R. Myopia control with orthokeratology contact lenses in Spain: refractive and biometric changes. Invest Ophthalmol Vis Sci. 2012 Jul 31;53(8):5060-5. doi: 10.1167/iovs.11-8005.
Results Reference
result
PubMed Identifier
27767354
Citation
Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutierrez-Ortega R, Sugimoto K. Long-term Efficacy of Orthokeratology Contact Lens Wear in Controlling the Progression of Childhood Myopia. Curr Eye Res. 2017 May;42(5):713-720. doi: 10.1080/02713683.2016.1221979. Epub 2016 Oct 21.
Results Reference
result
Learn more about this trial
Eleven Years of Menicon Z Night Contact Lens Wear in Reducing Myopia Progression in Children
We'll reach out to this number within 24 hrs